KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Retained Earnings (2016 - 2025)

Historic Retained Earnings for Biogen (BIIB) over the last 17 years, with Q4 2025 value amounting to $20.6 billion.

  • Biogen's Retained Earnings rose 671.29% to $20.6 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $20.6 billion, marking a year-over-year increase of 671.29%. This contributed to the annual value of $20.6 billion for FY2025, which is 671.29% up from last year.
  • Per Biogen's latest filing, its Retained Earnings stood at $20.6 billion for Q4 2025, which was up 671.29% from $20.6 billion recorded in Q3 2025.
  • Biogen's Retained Earnings' 5-year high stood at $20.6 billion during Q3 2025, with a 5-year trough of -$174.3 million in Q1 2021.
  • Its 5-year average for Retained Earnings is $8.6 billion, with a median of -$108.6 million in 2021.
  • Per our database at Business Quant, Biogen's Retained Earnings tumbled by 5652.17% in 2023 and then soared by 1202285.0% in 2024.
  • Biogen's Retained Earnings (Quarter) stood at -$106.7 million in 2021, then tumbled by 54.55% to -$164.9 million in 2022, then surged by 10789.87% to $17.6 billion in 2023, then grew by 9.26% to $19.3 billion in 2024, then grew by 6.71% to $20.6 billion in 2025.
  • Its last three reported values are $20.6 billion in Q4 2025, $20.6 billion for Q3 2025, and $20.1 billion during Q2 2025.